Autoimmune Diseases
FDA Approves Roche’s Gazyva for Lupus Nephritis, Bringing New Hope to 1.7 Million Patients Worldwide
2025-10-21
Biohaven’s Potential First-in-Class Autoimmune Therapy BHV-1300 Cuts Total IgG by Over 80%
2025-03-04
LATEST
Study Finds Treatment Variations in Immunobullous Disorders Linked to Demographic Factors
2026-01-24
Study Finds Orexin Receptor Agonists May Pose Higher Fracture Risk Compared to Melatonin Receptor Agonists
2026-01-24
Researchers Develop Distributed Method Using Control Barrier Functions to Enhance Network Connectivity
2026-01-24



